Drug Type Small molecule drug |
Synonyms STRAY-02, STRAY02 |
Target |
Action stimulants |
Mechanism SIRT1 stimulants(NAD-dependent deacetylase sirtuin 1 stimulants), Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Huntington Disease | Preclinical | United States | 09 Nov 2013 | |
| Huntington Disease | Preclinical | United States | 09 Nov 2013 |





